24 studies found for:    Open Studies | "Graves Disease"
Show Display Options
Rank Status Study
21 Unknown  The Role of TSH Receptor, PPAR-r, IGF-1R, IGF and Cytokines in Different Stages of Graves’Ophthalmopathy
Condition: Graves' Ophthalmopathy
Intervention:
22 Recruiting Twenty-four Hour Intraocular Pressure Patterns in Patients With Uncontrolled Thyroid Eye Disease
Condition: Thyroid Eye Disease
Intervention: Device: SENSIMED Triggerfish
23 Recruiting Treatment of Upper Eyelid Retraction Related to Thyroid-associated Ophthalmopathy Using Subconjunctival Triamcinolone Injections
Condition: Thyroid-associated Ophthalmopathy
Intervention: Drug: subconjunctival triamcinolone injection
24 Recruiting Tocilizumab Treatment in Graves´ Ophthalmopathy (Graves´ Orbitopathy or Thyroid Eye Disease)
Conditions: Thyroid Associated Ophthalmopathies;   Graves´ Ophthalmopathy;   Thyroid Eye Disease
Interventions: Drug: Tocilizumab (RoActemra®);   Drug: Sterile 0.9% Sodium Chloride

Show previous page of results Previous Page (1-20) Studies Shown (21-24) Next Page
Indicates status has not been verified in more than two years